Speech-Language Pathologists in Kodiak, AK Accepting Medicare

5 Speech-Language Pathologists found. Showing 1 - 5

Alaska Premier Therapy Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 204 E Rezanof Dr, Lower #2, Kodiak, AK 99615 Phone: 907-512-0979

Adrienne Chambers Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3449 E Rezanof Dr, Kodiak, AK 99615 Phone: 907-486-9870

Tina Clumpner, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 104 Center Ave, Suite 200, Kodiak, AK 99615 Phone: 907-512-0979    Fax: 907-512-3023

Ms. Christie Ann Chernoff, MA CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3175 Arctic Tern, Kodiak, AK 99615 Phone: 907-486-1761

Kodiak Cubs Speech Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 452 Lilly Drive, Kodiak, AK 99615 Phone: 907-395-7886

News Archive

Maven Semantic updates Lymphocyte Cell Biology research database

Maven Semantic announces updates to their Lymphocyte Cell Biology research database. The new database is now available to marketing, business development, competitor intelligence, KOL, medical affairs and related departments in the life sciences sector.

Emmaus receives EC Orphan Medicinal Product designation for Levoglutamide

Emmaus Medical, Inc., a specialty pharmaceutical and regenerative medicine technology company, and subsidiary of Emmaus Life Sciences, Inc., today announced that the European Commission (EC) has granted Orphan Medicinal Product designation for the company's investigational drug Levoglutamide (L-glutamine) for the treatment of sickle cell disease.

Increased inflammation following infection impairs brain's ability to form spatial memories

Increased inflammation following an infection impairs the brain's ability to form spatial memories - according to new research. The impairment results from a decrease in glucose metabolism in the brain's memory centre, disrupting the neural circuits involved in learning and memory.

Zenalux, RPCI collaborate to enhance Zenascope system to detect oral cancers at an early stage

Zenalux Biomedical, Inc., a leader in biophotonic diagnostics, is working with Roswell Park Cancer Institute to further enhance its flagship Zenascope™ product by adding a high-resolution camera to the system.

Merck announces interim analysis from V710 Phase II/III trial in S. aureus infection

Merck, known as MSD outside the United States and Canada, and Intercell AG today announced that following a pre-specified interim analysis from the Phase II/III clinical trial evaluating V710, an investigational vaccine for the prevention of Staphylococcus aureus infection, the independent Data Monitoring Committee recommended suspension of enrollment.

Read more Medical News

› Verified 3 days ago